Patients should not have to wonder whether the drugs the hospital gives them are going help save their lives or be the reason they don’t wake up the next day. For those who are given Xarelto (Rivaroxaban), such thoughts could cross their mind, seeing as the blood thinner has been making headlines for all the wrong reasons.
As we have blogged about previously, Xarelto is a blood thinner that has been linked to bleeding issues. Reportedly, in some cases, patients who are given Xarelto can have problems with their blood not clotting properly, leading to injuries and deaths caused by uncontrollable bleed outs.
Now, according to The State Journal, a patient is claiming that Bayer AG and Janssen, the makers of Xarelto, may have ignored studies that showed that the drug can raise patients’ risk of gastrointestinal bleeding. In a suit filed in late December, a woman who suffered a gastrointestinal bleed after taking Xarelto to treat atrial fibrillation claims the incident and the injuries it caused could have been prevented if Xarelto’s makers had not hidden the drug’s risks.
Why Are Xarelto Bleed Outs So Hard to Stop?
According to the report in the Journal, gastrointestinal bleeding caused by Xarelto can sometimes require transfusions, because bleeding caused by the drug can be potentially impossible to stop. The reason Xarelto bleed outs are so difficult to stop is because there is currently no antidote for the drug.
Colson Hicks Eidson – Injury Attorneys